Medical News and Events in South Africa
Medical News and Events in South Africa

Medical Industry News Archive

Click here to search our archive

Print using browser

URGENT MEDICINE RECALL: SANDOZ CEFPODOXIME 40mg/5ml Reg No A39/20.1.1/0397 (50ml and 100ml pack sizes)
Sandoz SA (Pty) Ltd in collaboration with the Medicines Control Council are initiating a Class 2, Type B recall on all batches of Sandoz Cefpodoxime 40mg /5ml (50ml and 100ml pack sizes).

Sandoz Cefpodoxime 40mg/5ml powder for oral suspension is an antibiotic used for short- term treatment of lower and upper respiratory tract infections in infants, children and adults.

The product is being recalled due to lower than expected efficacy, high unknown impurities, discolouration and formation of brownish agglomerates on certain batches of Sandoz Cefpodoxime 40mg/5ml tested during stability monitoring.

Use of the product may lead to weakened patient therapy through insufficient anti-infective treatment resulting in: a patient being contagious to others for a longer time, the development and spread of resistant bacterial strains, and significant therapeutic difficulties in eradication of respective bacteria.

In the interest of patient safety, Sandoz SA (Pty) Ltd request that you immediately return all batches of Sandoz Cefpodoxime 40mg/5ml stock without delay to your supplying wholesaler or distributor for full credit.
Sandoz SA (Pty) Ltd would like to thank you for your co-operation and apologise for any inconvenience caused.

Should you have any enquiries in this regard kindly contact the Sandoz Customer Call Centre 0861 SANCAL or 0861 726 225 during office hours and a technical support 24 hour call no 0768114744.

For full prescribing information please refer to package insert approved by Medical Regulatory Authority

Sandoz SA (Pty) Ltd PO Box 154, Isando 1600 Kempton Park, Gauteng South Africa Tel Fax +27 (0) 11 394 3084    Reg No: 1990/001979/07
Directors: R-A Bassoul (Canadian) J-C Dubos (French) M.M Paleja (Singaporean)  
A Novartis Company

You need to be logged in to see more details. Register Now!

Click here for more information .....
Contact: Carla Urbani-Smith, (Responsible Pharmacist)
Telephone: +27 (0) 11 929 9000
Date: Tuesday, February 14, 2012

Archive News Headlines
Sandoz launch - Sandoz Co-Amoxyclav 625mg Dispersible Tablets 16’s (amoxicillin, potassium clavulanate)
Biotech Laboratories - Out of Stock - Myoprin 100 mg tablets (Aspirin)
Cipla - Out of Stock - Foratec HFA Inhaler (formoterol fumarate)
Lamar - launch - Dri-Gon 15 ml Lubricating Dry Eye Solution
Aspen - Out of Stock - Betnesol-N Eye, Ear and Nose Drops (betamethasone,neomycin sulphate)
Sun Pharma - Stock Shortage - Zofer 8 mg Rapitabs (ondansetron)
Sun Pharma - Stock Shortage - Alapren 20 mg tablets (enalapril maleate)
Adcock - Out of Stock - Oculosan Drops 10ml (Zn-sulph, naphazoline)
Cipla - back in stock - Olexar 10 mg Tabs (olanzapine)
Pharma Dynamics - Out of Stock - Dynaval Co 160/25 mg (valsartan/hydrochlorothiazide)
Equity Pharmaceuticals - Penthrop Inhalation (methoxyflurane)
Aspen and GSK launch Keppra 500 mg tablets (levetiracetam)
Aspen/ Litha Pharma - Out of Stock - Pur-Bloka 10 mg tablets (propranolol hydrochloride)
Aspen - Out of Stock - Bactroban Topical Ointment (mupirocin)
Aspen - Out of Stock - Bactroban Nasal Ointment (mupirocin)
Aspen discontinue Diotroxin tablets (thyroxine sodium, liothyronine sodium)
Cipla - launch - Triamist (Triamcinolone acetonide)
Cipla - Out of Stock - Budeflam Aquanase (Budesonide)
MSD - Fosavance 5600 tablets (alendronate monosodium)
Sanofi - Back in Stock - Stilnox MR 12,5 mg tablets (zolpidem tartrate)